Posters

Assessment of intraocular pressure changes in patients undergoing 0.7 mg dexamethasone implant injection for macular edema

Poster Details

First Author: A.Ergin TURKEY

Co Author(s):    u. limon   I. Kutluturk Karagoz   P. Ergin                       

Abstract Details



Purpose:

To evaluate the intraocular pressure (IOP) changes in patients undergoing Ozurdex® injection for macular edema after diabetic retinopathy or retinal vein occlusion.

Setting:

The study was conducted in department of ophthalmology Health Sciences University Umraniye Training and Research Hospital in ─░stanbul

Methods:

In this retrospective study 50 eyes of 46 patients medical records who were treated with one 0.7 mg dexamethasone implant for macular edema secondary to retinal vein occlusion or diabethic retinopathy reviewed between 2014 and 2016 in our department. Intraocular pressure was measured with Goldman applanation tonometer. Changes in IOP at first, second and thirth months after one dexamethasone injection were recorded. Main outcome measures are IOP elevation and IOP elevation time.diabethic retinopathy reviewed between 2014 and 2016 in our department. Intraocular pressure was measured with Goldman applanation tonometer. Changes in IOP at firsth, second and thirth months after one dexamethasone injection were recorded. Main outcome measures are IOP elevation and IOP elevation time.

Results:

In the study there were 19 man and 27 woman. Patients mean age were 64.6 (range 42-85 years).The average duration of follow-up was 3 months. There was 28 eyes with diabethic macular edema and 22 eyes with retinal vein occlusion. Intraocular pressure increased (> 21 mmHg or an increase >5 mmHg between 2 consecutive visits) in 5 (%10) eyes. IOP increased in 2 patients in first month and in 3 patients in second month. Increaced IOP treated by medical therapy in all patients. No additional procedures (laser or surgery) were required to normalize IOP.diabethic retinopathy reviewed between 2014 and 2016 in our department. Intraocular pressure was measured with Goldman applanation tonometer. Changes in IOP at first, second and thirth months after one dexamethasone injection were recorded. Main outcome measures are IOP elevation and IOP elevation time.macular edema and 22 eyes with retinal vein occlusion. Intraocular pressure increased (> 21 mmHg or an increase >5 mmHg between 2 consecutive visits) at 5 (%10) eyes. At 2 patient IOP increased at firsth month and at 3 patient IOP increased at second month. At all patients IOP elevation reduced by medical therapy. No additional procedures (laser or surgery) were required to normalize IOP.

Conclusions:

Intraocular pressure has increaced in first and second month after dexamethasone implant injection in some of the patients. These patients were successfully managed with topical IOP-lowering medications.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy